Executive Director, US Portfolio Analytics

Role: Executive Director, US Portfolio Analytics, leading data-driven commercial decision-making for Revolution Medicines' US oncology business. Responsibilities: oversee portfolio analytics, including Field, Market Access, Omnichannel, and Reporting; develop analytics strategy, standards, and data governance; drive advanced analytics adoption; support product launch and lifecycle performance; partner with cross-functional teams; manage external vendors; lead and develop a high-performing analytics team. Requirements: 12+ years in biotech, pharma, or consulting with deep expertise in commercial analytics, including claims, prescription, HCP, payer, and digital data; proven leadership in building scalable analytics capabilities; strong business acumen and experience supporting product launches. Preferred: advanced degrees (MBA, MS, PhD), oncology or specialty therapeutics experience, familiarity with analytics platforms like IQVIA, Veeva, Tableau, Power BI. High-Value: commercial analytics, biopharma data sources, product launch support, strategic decision support, AI and advanced modeling. Work Setup: based in Redwood City, CA; role may involve collaboration across multiple biopharma data ecosystems.